Tissue-Specific Localization of the Feline Endocannabinoidome

By Will Scott | Published October 26, 2026

A cat experiences the world through tissues that must remain responsive without surrendering their stability. The mouth meets food and mechanical contact. The intestinal wall places epithelium, immune cells, muscle and nerves within the same narrow anatomical space. Skin carries another exposed boundary, while sensory neurons connect local events with the nervous system. Cannabinoid receptors and related molecular targets occupy these settings in distinct combinations, giving feline cannabinoid biology a cellular geography rather than a uniform whole-body distribution.^{[2][13][14][15][17]}

That geography reaches beyond CB1 and CB2. It includes receptors with different signaling partners, channels capable of changing cellular ion movement, nuclear receptors involved in gene regulation and enzymes that help determine the lifetime of endogenous lipid messages. In the cat, these components appear in oral and intestinal epithelium, inflammatory populations, enteric glia, reproductive structures, sensory ganglia and cerebral arterial muscle. Their significance emerges from the work performed by the cells around them.^{[1][2][13][14][16][18][19]}

The Local Life of an Endocannabinoid Signal

Endocannabinoid communication begins with molecules the body makes itself. Anandamide and 2-arachidonoylglycerol, usually abbreviated 2-AG, are the best-characterized members of this group. Unlike neurotransmitters accumulated in vesicles before release, these lipid messengers can be generated from membrane-associated precursors when cellular activity recruits the necessary enzymes. The location of that machinery helps determine where a message begins and which nearby targets it can encounter.^[1][3]

The two messengers do not share a single metabolic route. Diacylglycerol lipase contributes to 2-AG production, while anandamide can arise through several biosynthetic pathways. Their breakdown also involves different principal enzymes: monoacylglycerol lipase is important for 2-AG, whereas fatty acid amide hydrolase, or FAAH, contributes substantially to anandamide hydrolysis. A receptor map therefore describes only one part of the local signaling environment. Production and removal help determine how much messenger is available and how long its influence persists.^[1][4]

At many mammalian synapses, this arrangement supports retrograde communication. Activity in a receiving neuron can promote endocannabinoid production, allowing a lipid messenger to act on CB1 receptors associated with the transmitting terminal and reduce further neurotransmitter release. The direction of that message gives the receiving cell a means of influencing its incoming signal. This general synaptic mechanism explains why the relative positions of receptors and enzymes matter, without establishing a corresponding anatomical map for every feline brain region.^[5]

CB1 and CB2 translate ligand binding through intracellular signaling proteins. Their coupling commonly involves Gi/o proteins, with effects on adenylyl cyclase, ion channels and kinase pathways that vary with the cellular setting. The receptor is consequently an entry point into a larger response, not a complete physiological instruction by itself. A muscle cell and a neuron can contain related receptor machinery while producing different measurable consequences because their downstream organization differs.^[6][19]

Several Molecular Routes Share the Same Landscape

Plant cannabinoids enter this landscape with their own pharmacological identities. THC, CBD and THCV differ in affinity, efficacy and the conditions under which they influence CB1 or CB2 signaling. The presence of a classical cannabinoid receptor therefore does not make every cannabinoid an equivalent ligand for that receptor. The amount of receptor, its coupling to the cell and the compound reaching it all influence the response. Anatomical abundance and pharmacological potency describe different parts of the interaction.^[7]

GPR55 adds another receptor pathway, with pharmacology distinct from CB1 and CB2. Recombinant human receptor experiments connect it with cannabinoid-responsive signaling and intracellular calcium-related pathways, explaining its place in the broader endocannabinoidome. Those experiments supply a molecular context for the GPR55-associated signals found in feline tissues. They do not establish that every ligand response observed in the recombinant system occurs with the same potency or consequence in a feline epithelial or immune cell.^[8][13][14]

PPAR-alpha belongs to a different class altogether. As a nuclear receptor, it participates in transcriptional regulation through interactions with other proteins and DNA response elements. Lipid mediators associated with the endocannabinoidome can engage PPAR pathways in experimental systems, connecting this receptor family with metabolism and inflammatory regulation. Its appearance in feline enteric glia or epidermis consequently introduces a regulatory dimension distinct from the immediate ion movement associated with an activated channel.^[9][14][15]

TRP channels contribute that channel-dependent dimension. Different cannabinoids can activate, desensitize or inhibit selected TRP channels under experimental conditions, and the response varies with both the compound and the channel. TRPA1, TRPV1, TRPV2 and TRPM8 are therefore not interchangeable names for a common cannabinoid effect. Their separate identities become especially important in feline anatomy, where TRPA1-associated labeling in oral or intestinal cells and capsaicin-sensitive TRPV1 responses in sensory neurons describe different biological locations.^{[10][13][14][17]}

The Oral Surface and the Tissue Beneath It

The healthy feline oral mucosa carries a layered receptor-associated pattern. CB1 labeling is prominent toward the superficial epithelial layers, while the basal layer lacks the same detectable signal. CB2 and GPR55 are generally absent from the healthy epithelial compartment under the examined conditions, yet cells beneath the surface can carry those signals. A short movement through the depth of the mucosa thus crosses a meaningful molecular boundary: the epithelial surface and the subepithelial populations do not share one uniform profile.^[13]

TRPA1 and 5-HT1A extend the oral pattern beyond the classical cannabinoid receptors. Their distribution places a channel and a serotonin receptor within the same broader anatomical discussion, while retaining the distinct identity of each target. In healthy controls, deeper epithelial 5-HT1A signal occurred in three of the four samples assessed for that observation. Even before disease enters the picture, the oral mucosa contains variation between layers and between individual animals.^[13]

Chronic gingivostomatitis changes the setting dramatically. Altered epithelium lies above inflammatory infiltrates, and several studied targets show stronger or more extensive labeling in that diseased environment. The distribution reflects both a changed surface and the cellular populations accumulating beneath it. An inflammatory cell carrying CB2 or GPR55 belongs to a different anatomical compartment from an epithelial cell carrying CB1, even when the two appear within the same affected region.^[13]

The epithelial 5-HT1A pattern remains notably variable during gingivostomatitis: three of eight affected cats showed positive epithelial labeling and five did not, while some inflammatory cells were positive in all eight. Disease therefore does not impose one identical receptor profile across every mouth. The oral landscape is shaped by the target, its cellular location and the individual tissue response. Preserving those distinctions gives a more useful account of the inflamed mucosa than describing every component as universally increased.^[13]

The Intestinal Wall Contains Adjoining Molecular Territories

Along the feline gastrointestinal tract, related targets occupy epithelial, immune, muscular and enteric neural compartments. CB1-associated signal appears in gastric epithelial cells, intestinal enteroendocrine cells and goblet cells, lamina propria mast cells and enteric neurons. These locations bring the same receptor-associated identity into several different cellular settings. The intestinal wall contains them together, but a signal within a neuron does not describe the same anatomical relationship as a signal within an epithelial cell.^[14]

CB2 follows a separate pattern through enteroendocrine cells, enterocytes and macrophages. Goblet cells add a regional distinction: small-intestinal goblet cells were negative under the examined conditions, whereas large-intestinal goblet cells were positive. The position along the digestive tract therefore belongs to the receptor’s address. A general statement that feline intestinal goblet cells express CB2 would conceal the boundary between the small-intestinal and colonic observations.^[14]

GPR55 reaches enteroendocrine cells, macrophages, other immunocytes and myenteric neurons. Within the immune compartment, however, the signal does not extend indiscriminately to every identified population. GPR55 labeling did not colocalize with the CD3-positive T cells or IgA-positive plasma cells examined. The presence of positive immunocytes and the absence of those particular marker associations define the same anatomical picture from different directions. Both are needed to keep the cellular identities intact.^[14]

PPAR-alpha-associated labeling occurs in immunocytes, smooth muscle cells and enteroglial cells. This places a nuclear receptor within the muscle and neural environment of the gut without making glia equivalent to neurons. The distinction matters because enteric neural tissue contains more than electrically active neuronal cell bodies. A receptor-associated pattern within its glial component introduces a different cellular setting for lipid-linked regulation, one that would disappear inside a loose reference to intestinal nerves.^[9][14]

TRPA1 links another pair of compartments through labeling in enteric neurons and fibers as well as intestinal goblet cells. The 5-HT1A pattern, meanwhile, includes gastrointestinal epithelial cells and gastric smooth muscle, with feline enteric neurons negative under the tested conditions. CB2 likewise lacked a reported enteric neuronal or glial signal. The gut therefore does not distribute every target through every available layer; its molecular organization is selective at the level of both region and cell population.^[14]

This close arrangement of different targets creates several possible points at which local signaling could influence intestinal behavior. The epithelium, immune cells, muscle, neurons and glia provide distinct biological contexts rather than duplicate versions of the same receptor field. Which location governs a particular change in motility, sensation or inflammation requires functional evidence appropriate to that compartment. The anatomy supplies the coordinates for those questions without assigning the same answer to every cell in the wall.^[14]

Skin Reorganizes the Pattern During Hypersensitivity

Healthy feline skin contains detectable CB1, CB2 and PPAR-alpha signals, with the epithelial compartment prominent in their distribution. During hypersensitivity-associated eosinophilic dermatitis, expression increases and the pattern changes within particular layers. Suprabasal CB1 labeling places part of that change above the basal epidermal layer, while altered dermal CB2 localization extends the picture into the tissue beneath the surface.^[15]

PPAR-alpha becomes particularly apparent in hyperplastic epidermis and perivascular infiltrates. The thickened surface and the inflammatory populations around vessels consequently contribute different parts of the molecular landscape. This is more than a numerical increase in a whole-skin measurement. The receptor-associated signals have positions within an altered structure, and those positions help define how diseased skin differs from its healthy counterpart.^[15]

The affected samples included substantial injury, with ulceration present in six of seven cats. Their distribution therefore belongs to an inflammatory setting in which tissue architecture and cellular composition were already changed. Increased target expression within that environment is compatible with an adaptive response, but the labeling itself does not establish whether the response successfully controls disease. The skin can carry more detectable signaling machinery while remaining visibly and clinically inflamed.^[15]

The cutaneous picture places cannabinoid biology at the intersection of epithelial change and inflammatory infiltration. It also preserves a distinction between identifying a target-associated signal and identifying every cell carrying it. Some immune-cell descriptions rely on morphology rather than a separate colocalization marker for each population. The secure anatomical account follows the demonstrated epidermal, dermal and perivascular compartments without assigning an unsupported identity to every labeled cell.^[15]

The Ovary and Oviduct Pair Receptors with Metabolic Machinery

In the feline ovary, CB1 and FAAH occupy overlapping but nonidentical territories. CB1 labeling occurs in granulosa cells of tertiary follicles, while more immature follicles were negative in the sampled tissue. FAAH has a broader follicular distribution, including oocyte cytoplasm and granulosa cells of primary, secondary and tertiary follicles. The enzyme-associated pattern consequently extends into structures that do not share the same detectable CB1 distribution.^[16]

Luteal cells carry signals for both components. This juxtaposition is useful because receptor presence and local lipid metabolism concern different parts of the signaling process. FAAH is associated with the breakdown of anandamide and other fatty acid amides, whereas CB1 provides a receptor pathway for responsive cells. Their coexistence offers an anatomical basis for investigating local regulation, although the labeling does not measure the amount of ligand or the activity of the enzyme in that tissue.^[1][16]

The oviduct supplies a particularly clear cellular boundary. CB1-associated signal occurs in ciliated epithelial cells, while FAAH immunoreactivity appears in both ciliated and nonciliated cells. The receptor’s reported territory is therefore narrower than the enzyme’s across the same epithelial surface. Neighboring cells share part of the molecular environment without carrying an identical combination of its components.^[16]

These reproductive coordinates belong to nonpregnant cats sampled during diestrus. Differences among follicles, luteal tissue and oviductal cells describe the structures present within that physiological setting. They do not establish a sequence of receptor changes across the entire sexual cycle. Their biological value is spatial: they locate receptor-associated and metabolic machinery within specialized feline reproductive compartments, giving future functional questions a precise starting point.^[16]

Sensory Neurons Reveal How Long a Response Persists

Feline sensory ganglia add a dimension that a static tissue section cannot provide: the behavior of a responsive cell through time. Capsaicin evokes currents in selected dorsal root ganglion neurons, giving a functional TRPV1-related readout. In neurons from cats with feline interstitial cystitis, the capsaicin response desensitized more slowly than in control neurons. The difference concerns the persistence of cellular responsiveness rather than merely the presence of a detectable target.^[17]

Protein kinase C contributes to that altered pattern. Pharmacological activation could reproduce relevant response changes, while inhibition reduced them. The channel-related phenotype is therefore linked to an intracellular signaling process capable of modifying the response. Direct phosphorylation of the channel was not measured, so the evidence supports a pharmacological relationship without establishing every molecular step between kinase activity and the recorded current.^[17]

The sensory population came from L4 to S3 ganglia, with bladder-associated neurons identified through retrograde labeling in a subset of the experiments. Later recordings also included unlabeled cells, and the neurons had been maintained in culture for two to five days. These conditions define the functional setting: a selected feline sensory population with demonstrated urinary connections in part of the sample, rather than a complete intact-bladder circuit.^[17]

A broader feline sensory-channel profile includes calcium responses to challenges directed toward TRPA1, TRPV2 and TRPM8 as well as TRPV1. In healthy L3 to L5 ganglion cultures, different subsets responded to allyl isothiocyanate, probenecid, icilin and capsaicin under the tested conditions. The population consequently contains several experimentally accessible response types, rather than one channel identity shared uniformly by every cultured neuron.^[18]

Separate L5 tissue measurements detected transcripts for several TRP channels, MRGPRD, TAC1 and GFRA3. Numerical differences between healthy cats and cats with degenerative joint disease did not reach statistical significance in the tested group comparisons. Functional calcium imaging used healthy neurons, not a healthy-versus-diseased functional comparison. The established sensory profile is therefore broader than the evidence for any particular disease-associated increase in channel activity.^[18]

Cerebral Arterial Muscle Connects CB1 with Vascular Behavior

Feline cerebral arterial smooth muscle provides a defined vascular location for CB1-associated machinery. A receptor-related transcript is supported by amplification, cloning and sequencing, alongside protein-associated evidence from Western blot analysis. The molecular findings place CB1 within the vascular smooth-muscle preparation before its effect on cellular current or vessel tone is considered.^[19]

Anandamide and the synthetic agonist WIN-55,212-2 inhibit a recorded L-type channel current in freshly isolated cerebral smooth-muscle cells. The antagonist SR-141716A prevents the agonist-associated inhibition, while pertussis toxin treatment abolishes the inhibitory responses. The receptor-related effect consequently depends on a pertussis toxin-sensitive signaling component within the cell. The recordings used barium as the charge carrier, preserving an important distinction between the experimental current and physiological calcium movement in a living cat.^[19]

At the vessel level, isolated cerebral arterial segments relax when exposed to increasing concentrations of those agonists after pressurization and serotonin-induced constriction. Antagonist pretreatment substantially attenuates the relaxation. Cellular electrophysiology and arterial behavior therefore converge on a CB1-associated vascular mechanism, joining molecular presence with a measurable response in a feline tissue preparation.^[19]

This mechanism offers a plausible route through which endogenous cannabinoid signaling could influence cerebral arterial tone. Its contribution to regional blood flow in the living cat remains unresolved. The anatomical location also remains specific: arterial smooth muscle is not a neuronal atlas of cortex, hippocampus or cerebellum. The vascular wall contributes its own evidence to the feline endocannabinoidome without having to represent a different compartment of the brain.^[19]

Bladder Regulation Separates Two Neural Routes

Bladder control demonstrates how cannabinoid-associated signaling can become visible at the level of a physiological pathway. In anesthetized cats with chemically induced bladder irritation, tibial and pudendal nerve stimulation both inhibited overactivity. Systemic administration of the antagonist AM251 reduced the inhibition associated with tibial stimulation, while the pudendal-stimulation effect was retained under the tested conditions.^[20]

The two stimulation routes therefore did not share the same sensitivity to receptor blockade. Intrathecal antagonist administration at the investigated L7 site did not reproduce the systemic effect on tibial inhibition, leaving the exact receptor-bearing location unresolved. A functional contribution can thus be clearer than its cellular address: the experiment identifies a CB1-associated component of the tested neuromodulatory response without locating every cell responsible for it.^[20]

Beside the sensory-neuron findings, this creates a layered urinary picture. Capsaicin-responsive cells reveal a modifiable channel-related phenotype, while nerve stimulation reveals a receptor-sensitive physiological pathway. The observations concern different levels of organization and need not be forced into one continuous mechanism. Their combined value is a feline foundation for investigating how local cellular responsiveness relates to the larger control of bladder behavior.^[17][20]

Keeping the Cellular Boundaries in Focus

Immunolabeling gives these tissue relationships spatial form, but the signal depends on antibody behavior and specimen preparation. Independent validation approaches can strengthen identification through genetic strategies, comparison with another method or agreement between antibodies recognizing different epitopes. A negative result likewise belongs to the conditions under which the tissue was examined, rather than proving permanent absence across every possible physiological state.^[11][12]

With those boundaries preserved, the feline pattern is strikingly coherent. Oral epithelium differs from its infiltrate; intestinal neurons differ from glia and goblet cells; inflamed skin differs from healthy skin; and reproductive cells divide receptor and enzyme machinery among neighboring populations. The common feature is not uniformity but local organization.^{[13][14][15][16]}

Function adds depth to that organization. A sensory neuron can change the persistence of its response, arterial muscle can alter a voltage-dependent current, and a neuromodulatory pathway can lose part of its inhibitory effect during receptor blockade. The feline endocannabinoidome emerges through these particular cells and particular responses. Its anatomy provides a foundation for precise questions, allowing future therapeutic work to begin with where the biology actually happens.^{[17][18][19][20]}